Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin.
A patient underwent an HLA-identical ABO-compatible allogeneic bone marrow transplant for aplastic anemia. She then developed pure red cell aplasia which was treated successfully with antithymocyte globulin and methylprednisolone, after failing to respond to intravenous immune globulin infusion.
Roychowdhury
D F
DF
Department of Medicine, University of California, San Francisco 94143-0324, USA.
Linker
C A
CA
D000017:ABO Blood-Group System / Q000276:immunology; D000328:Adult; D000741:Anemia, Aplastic / Q000276:immunology / Q000601:surgery*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006650:Histocompatibility Testing; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use*; D012010:Red-Cell Aplasia, Pure / Q000209:etiology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous
D000017:ABO Blood-Group System; D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D008775:Methylprednisolone